{"id":"W2986312172","doi":"10.25251/skin.3.supp.39","title":"Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT)","year":2019,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Certolizumab pegol; Placebo; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Multicenter study; Internal medicine; Dermatology; Adalimumab; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008733111,0.001356329,0.004256478,0.000587333,0.0004240258,0.00132435,0.0008109319,0.002149747,0.003357616],"category_scores_gemma":[0.00764849,0.0007985915,0.005025735,0.0006975676,0.0008926615,0.001414271,0.0004318883,0.002615171,0.0006266401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005374987,"about_ca_system_score_gemma":0.0007041341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005159294,"about_ca_topic_score_gemma":0.0006079936,"domain_scores_codex":[0.9975845,0.001349194,0.0002721252,0.0003646803,0.0002872598,0.0001422569],"domain_scores_gemma":[0.9932806,0.002932679,0.002118346,0.0006066155,0.0005175245,0.000544193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9094241,0.001344953,0.004545648,0.004323327,0.02258061,0.00007487448,0.0000904781,0.001233812,0.007294633,0.00007842619,0.001311765,0.04769734],"study_design_scores_gemma":[0.7878245,0.121293,0.05084507,0.0006421666,0.03053155,0.0003916112,0.00009374955,0.001314698,0.003965198,0.0005250301,0.002474922,0.00009861309],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8637459,0.1202305,0.003688512,0.001138844,0.0007246833,0.002568325,0.004378397,0.0003396381,0.003185173],"genre_scores_gemma":[0.9795521,0.01422581,0.001365744,0.0007159655,0.0004826367,0.0007927772,0.002113633,0.00004704538,0.0007043938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008733111,"threshold_uncertainty_score":0.04618567,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02894658660659985,"score_gpt":0.2972223779139177,"score_spread":0.2682757913073179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}